Progress report on the prophylactic use of oral hypoglycemic drugs in asymptomatic diabetes: neurovascular studies.
D000328:Adult; D000787:Angina Pectoris / Q000453:epidemiology; D001158:Arteries / Q000503:physiopathology; D001786:Blood Glucose / Q000032:analysis; D002318:Cardiovascular Diseases / Q000401:mortality*; D002561:Cerebrovascular Disorders / Q000453:epidemiology; D003920:Diabetes Mellitus / Q000188:drug therapy*; D003925:Diabetic Angiopathies / Q000453:epidemiology* / Q000503:physiopathology; D003929:Diabetic Neuropathies / Q000453:epidemiology* / Q000503:physiopathology; D005069:Evaluation Studies as Topic; D005230:Fatty Acids, Nonesterified / Q000097:blood; D005260:Female; D005951:Glucose Tolerance Test; D006801:Humans; D007328:Insulin / Q000097:blood; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000453:epidemiology; D009431:Neural Conduction; D010525:Peripheral Nerves / Q000503:physiopathology; D010629:Phenformin / Q000627:therapeutic use*; D011674:Pulse; D014044:Tolbutamide / Q000627:therapeutic use*
D001786:Blood Glucose; D005230:Fatty Acids, Nonesterified; D007328:Insulin; D014044:Tolbutamide; D010629:Phenformin